StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $50 at H.C. Wainwright
May 19, 2026 6:46 AM
(Updated - May 19, 2026 6:48 AM EDT)
H.C. Wainwright analyst Mitchell Kapoor lowered the price target on BioMarin ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change